spacer
home > ict > summer 2007 > image conscious
PUBLICATIONS
International Clinical Trials

Image Conscious

In adopting a medical imaging strategy, Gunter Bellaire of Perceptive Informatics assesses the potential variability of imaging data collected in multicentre trials, and the variability introduced when interpreting that data

Imaging modalities such as computer tomography (CT) and magnetic resonance imaging (MRI) can provide insight into drug efficacy and safety in a non-invasive way that often provides a faster way to reach traditional clinical endpoints (1).

In the past, even for pivotal studies, only site assessments of imaging data (local image review) were taken into account for study result analysis. However, in recent years, the value of a centralised imaging review has been acknowledged and continues to grow in popularity, making it now the method of choice, particularly for pivotal studies (2). In particular, the standardisation of image acquisition, and independence from clinical patient information, supports the objectivity of image analysis.

The independent centralised review (ICR) process aims for the reproducible outcome of expert image review (3,4). There are ways to assess reproducibility, such as comparing the variability among multiple expert reviewers, or looking at the variability of a single reviewer over time. The features of the central review that contribute to reproducibility are: standardised image acquisition; site and reviewer training; and tools to support the review process. This articles focuses on these aspects and discusses the potential effects attributed to each one.

STANDARDISED IMAGE ACQUISITION

Imaging modalities nowadays are highly complicated devices with various degrees of functioning/flexibility. The overall imaging modalities of choice are usually defined in the study protocol. In a multicentre clinical trial, the local imaging standards and the variety of available modality generations and individual software packages (5), which are defined for local usage, require a considered decision to provide guidance for image acquisition that meets the needs of such a trial.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Gunter Bellaire, PhD, is the Director of Operations at Perceptive Informatics (a PAREXEL International Company), based in the Berlin office for worldwide medical imaging operations. Before taking his post as Director of Operations, Gunter led the EU Perceptive Operations for medical imaging, interactive voice response systems and web solutions. Prior to joining Perceptive in June 2002, he was CTO at MedliveTV. Gunter has also worked as a Senior IT Manager for companies dealing with electronic patient records, medical portals, integrated hospital, and GP information systems.
spacer
Gunter Bellaire, PhD
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

AstroNova introduces its range of grass paper labels derived from grass for high quality organic products

Dietzenbach, 29 April 2019, AstroNova GmbH, European headquarters of AstroNova Inc. (RI, USA), responsible for Sales and Customer Service in Europe, the Middle East and Africa (EMEA), is extending its Product Identification range with new approved labelling for direct foodstuff contact.
More info >>

White Papers

Faster, Better, Cheaper: Lean as a Driving Force Behind Pharmaceutical Companies’ Growth

TBM Consulting Group

The pharmaceutical industry faces countless challenges: patent expirations, weak product development pipelines, downward pricing pressure and an increasingly burdensome regulatory environment. The most important question for companies is now “How can we position ourselves optimally to be successful in the long term?” Some pharmaceutical companies used the economic downturn in 2009 to embrace measures in the fields of cost reduction and efficiency increases, which can be implemented at short notice. The continuous and consistent implementation of sustainable measures that guarantee stability and form the basis for future growth was not necessarily paramount within this.
More info >>

 
Industry Events

World Pharma Week 2019

17-20 June 2019, Seaport World Trade Center, Boston

World Pharma Week will bring together a unique and international mix of large and medium pharmaceutical and biotech companies, CROs, leading universities and clinical research institutions, emerging companies and tool providers—making it a perfect meeting-place to share experience, foster collaborations across industry and academia, and evaluate emerging technologies.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement